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Abstract 
THE EXTRACTION OF TYPE I1 COLLAGEN AND THE ELECTROSPINNING OF 
NANO-FIBROUS SCAFFOLDS 
By Danielle Careen Knapp, M.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science in Biomedical Engineering at Virginia Commonwealth University. 
Virginia Commonwealth University, 2005. 
Major Director: Gary L. Bowlin, Ph.D., Associate Professor, Louis and Ruth Harris 
Exceptional Professorship, Biomedical Engineering 
Articular cartilage lining joints, such as in the knee, functions to reduce friction 
and absorb shock. Collagen type I1 is the largest constituent in the extracellular matrix of 
articular cartilage and its restoration is of the highest interest to tissue engineers. 
Cartilage has little ability to naturally regenerate due to the absence of vascularity and the 
inability of the chondrocytes to proliferate at a high rate. It would be ideal to create a 
mimicking extracellular matrix/scaffold from type I1 collagen that could possibly be used 
to replace damaged articular cartilage that has the same function and morphology. Three 
different groups of cartilage chips were utilized to extract type I1 collagen. The yield of 
the three groups was compared. The extracted type I1 collagen from the three groups was 
electrospun at the concentrations of 0.06,0.08,0.10 and 0.12 g/mL. Both the pore size 
and fiber diameter were analyzed. A SDS-Page was performed on the material to assure 
it was pure type I1 collagen and that no collagen type I contamination was present. 
Introduction and Background 
Researchers have utilized electrospinning over the years for materials that are 
both natural and synthetic in nature. Articular cartilage has proven to be a large problem 
located in the knees of aging individuals. This tissue is unable to easily regenerate 
naturally due to the absence of vascularity and the inability of chondrocytes to proliferate 
at a high rate. It is highly desirable to find a way to create a scaffold that could mimic the 
morphology and function of natural articular cartilage. Because articular cartilage is 
composed mainly of type I1 collagen, this material was electrospun into multiple 
scaffolds with varying fiber diameter and pore size in order to find an optimal 
extracellular matrix that could possibly be seeded with chondrocytes, potentially creating 
tissue engineered cartilage. 
Anatomy of Articular Cartilage 
Research over the years has proven that there are over 27 collagen types. Every 
collagen molecule is made up of three alpha chains wound in a triple helix configuration. 
Collagen type I1 consists of three specific alpha1 (11) chains that form its right-handed 
triple helix configuration. Type I1 collagen is of the highest concentration in articular 
cartilage. This tissue can be found at the ends of all articulating joints such as the tibia 
and femur. Articular cartilage is the thin layer of connective tissue that covers the 
surfaces of the bones in the synovial joints. This layer varies in thickness according to its 
location, ranging from one rnrn in the finger joint up to six rnm in the knee joint (Hasler 
1 
et al. 4 16). Articular cartilage functions to transmit weight-bearing loads placed on the 
joints in the body from one bone to another. This allows the stresses on the subchondral 
bone to be correctly distributed and allows for low friction movement. There are high 
amounts of cyclic stresses that are induced on all the joints in the body (knee joint in 
particular), on a daily basis. The structure and composition of articular cartilage are what 
allows this tissue to properly function inside the body. 
The composition of articular cartilage includes cells that are referred to as 
chondrocytes, which are imbedded in the extracellular matrix. The unique quality of 
articular cartilage is that it is completely aneural and avascular. Cartilage receives its 
nutrients via diffusion from the synovial fluid. In mature adult cartilage, chondrocytes 
make up only 10% of the total volume (Hasler et al. 417). The rest of the extracellular 
matrix is composed of water, electrolytes, collagens, proteoglycans, and glycoproteins. 
Proteoglycans are large biomolecules composed of a long protein core and 
glycosaminoglycan chains that are attached along its length. The protein core only makes 
up 10% of the molecular weight of the proteoglycans, and the glycosaminoglycan chains 
make up the other 90%. The glycosaminoglycan chains hold a highly negative charge, 
which allows the proteoglycans to have a high charge density, giving rise to a large 
osmotic swelling pressure. There are two main types of proteoglycans present in 
cartilage. The first is a larger set that includes aggrecan and versican and a smaller set 
that includes biglycan, decorin, fibromodulin, and lumican. The most abundant 
proteoglycan overall is aggrecan, which is made up of a protein core with chondriotin 
sulfate and keratin sulfate chains attached along its length. An illustration of a 
proteoglycan aggregate can be seen below in Figure 1. 
Proteoglycan Aggregate Molecule 
Hyaluronate 
Link Proteins 
binding Region 
Sulfate Rich Region 
Chondroitin sulfate rich region 
Figure 1: Proteoglycan Aggregate (Mironowicz et al. www.wor1dortho.com) 
Because of the high weight-bearing load the articular cartilage must support, 
stiffness and durability are largely important. The strength of this tissue depends on the 
molecular structure and the size of the proteoglycan aggregates. As cartilage matures, a 
large problem exists due to the degeneration of the tissue. The constant large weight- 
bearing load that is placed on the knee causes a change to occur in the aggrecan 
concentration. This concentration is decreased along with the length of 
glycosaminoglycan chains. With this large decrease in material inside the articular 
cartilage, the water content then increases causing a downward shift in the stiffness of the 
tissue. This can lead to mechanical damage because the articular cartilage no longer 
holds the same strength and pressure resistance as before. 
Besides collagens and proteoglycans, the articular cartilage is composed of many 
noncollagenous proteins. These proteins include fibronectin, thrombospondin, 
chondroadherin, link protein, cartilage matrix oligomeric protein, and cartilage matrix 
proteins. 
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As mentioned before the chondrocytes in articular cartilage receive their 
- -~ 
nutrients from the synovial fluid inside the tissue. The tissue fluid is made up of water 
with dissolved gas. Water is actually the main component of articular cartilage, making 
up 60-85% of its wet weight (Hasler et al. 423). The water is present in three areas of the 
cartilage: inside the chondrocytes, in the intrafibrillar space of collagen, and inside the 
domain of the proteoglycans. This high fluid content is important to the articular 
cartilage because the mobile cations of the water bind with the highly negative charge of 
the proteoglycans to produce a swelling pressure in the cartilage. This swelling pressure 
acts almost like a cushion that responds to the high stresses at the joints. The 
proteoglycans play a key role within the tissue because they are the main determinate of 
the swelling pressure inside the tissue, which dictates the strength, stiffness, and the 
ability to withstand pressure exerted on articular cartilage. 
The chondrocytes are the only cell type that reside in the composition of articular 
cartilage. These cells synthesize the matrix components, organize the matrix 
composition, and control the eventual degradation of these components inside the 
extracellular matrix. There is no cell-to-cell communication between chondrocytes and, 
as previously addressed, cartilage lacks blood and lymphatic vessels, which is why these 
cells receive all nutrients via diffusion through the extracellular matrix. This means that 
any change in fluid flow due to any stress or strain induced on the tissue can affect the 
productivity of the chondrocytes. Changes in the chemical factors, such as taking various 
medications, or the matrix coinposition can also influence the normal function of the 
chondrocytes. If the cells aren't in a normal or "happy" state, degradation of the articular 
5 
cartilage will occur because the cells aren't synthesizing the matrix components and 
properly diffusing nutrients in and out of .the tissue. 
Zones and Regions of Articular Cartilage 
Articular cartilage is not a homogenous tissue; instead, it has four zones that are 
organized vertically which are distinctly different from one another. There are also three 
matrix regions that exist in layers around the chondrocytes. The superficial zone is the 
zone farthest from the actual subchondral bone. This zone is the thinnest of the four and 
functions to provide a gliding surface for the end of the joint. The collagen fibrils are 
arranged parallel to the articular surface. Because of the thinness of the zone, the fibrils 
have a small diameter and are packed in a highly dense manner. The chondrocytes are 
flat and inactive in this zone. Also, both the aggrecan content and the cell volume are 
decreased, while the cell density is increased. The proteoglycans and collagens are 
densely packed and closely interconnected in this zone, providing a strong structure to 
reduce the stresses produced at the surface of the bone due to motion. 
Below the superficial zone is the transitional zone, which has a much greater 
thickness. The collagen fibrils are more loosely (randomly) arranged and have a larger 
diameter. The chondrocytes resume a more normal rounded shape, which allows them to 
be both larger and more active. This zone holds the highest proteoglycan content. 
The radial zone lies beneath the transitional zone and is divided into two separate 
areas-the upper and lower radial zone. The collagen fibrils are loosely organized in a 
perpendicular fashion with respect to the subchondral bone. They have their largest 
diameter in this zone. The water content is very low in this zone and the proteoglycan 
content is high. The metabolic activity of the chondrocytes is at its highest. 
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The deepest zone is the calcified zone, which lies between the deep zone and the 
- -. 
subchondral bone plate. There is a separation that exists between the deep zone and the 
calcified zone called a tidemark. This zone is a bit stiffer than the others because the 
cartilage is mineralized with crystals of calcium salts. The proteoglycan content is low 
and the collagen fibrils are arranged starting from the deep zone and insert into the 
calcified zone acting as an anchor for articular cartilage to be attached to the underlying 
subchondral bone. This zone serves as a structural integration mechanism between the 
articular cartilage and the underlying subchondral bone (Hasler et al. 426). Below, in 
Figure 2, is a diagram illustrating the four zones and three regions existing in articular 
cartilage. 
Radial 
zone 
I Articular aurfaco I 
Pericallular 
region 
Territorial 
- region 
. Interterritorial 
region 
Ttde mark 
_ Hypomphic 
c hondroc yte 
. Subchondral 
bone 
Figure 2: Four Zones and Three Regions of Articular Cartilage (Hasler et al. 424) 
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There are three matrix regions surrounding the chondrocytes. The pericellular 
matrix is the layer immediately surrounding the cells. The chondron is a term that refers 
to the chondrocyte and the pericellular matrix, which acts as the structural and functional 
unit of the cartilage. There is a rapid rate of turnover for the matrix components in this 
region due to the high presence of proteoglycans. Collagen filaments are thin in this 
matrix region, ranging from 10 to 15 nrn in diameter (Hasler et al. 426). The pericellular 
matrix acts as a protective barrier for the chondrocytes against the high mechanical 
pressures that are exerted on this tissue. 
The territorial matrix is a woven network of fine cartilage fibrils that are located 
around the pericellular matrix. Within the radial zone, the territorial matrix is organized 
in a way that it actually surrounds columns of chondrocytes. The chondrocytes have 
cytoplasmic projections that allow them to come into contact with the collagen fibrils 
located within this zone. 
Lastly, the interterritorial matrix of articular cartilage is both the outermost layer 
and the largest of the three in size. As the distance at which the collagen fibrils are 
located is increased from the chondrocyte they surround, the collagen fibrils increase in 
size. Therefore, collagen fibrils will be larger the farther away they are located from the 
chondrocyte it is surrounding. The proteoglycan content is decreased in this area. 
Functions of Articular Cartilage 
As previously mentioned, the largest task of articular cartilage is the ability to 
resist compression. The idea of cartilage swelling due to a pressure gradient is a large 
contributing factor to helping with this task. There are negatively charged groups 
connected to the glycosaminoglycan chains, giving cartilage a highly negative charge 
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density. In the synovial fluid there are positively charged sodium and calcium ions 
- - .  
floating around that are attracted to the GAGs, which will allow for the existence of 
electroneutrality. When there is an imbalance of ions inside of the tissue that is higher 
than that of the external solution, an osmotic pressure is created. The negative charges on 
the GAGs produces a strong repelling force, which causes the extracellular matrix within 
the articular cartilage to swell. The collagen mesh has the ability to balance the swelling 
of the proteoglycans and return the tissue to its normal state. As weight is put onto the 
joint, the proteoglycans are pushed out of the cartilage (the negative charge is pushed out 
of the tissue as well), which increases the charge density. Both the osmotic and 
interstitial fluid pressure within the matrix are now increased. The ideal situation is for 
the interstitial fluid pressure to rise above the osmotic pressure, allowing the interstitial 
fluid to exude and increase the proteoglycan content. The abundance of proteoglycans 
leads to an increase in the repulsive forces until an equilibrium is formed that has the 
ability to withstand the applied load. This is how the articular cartilage has the ability to 
resist compressive forces in the joints of the body. 
Articular Cartilage Limitations 
As humans mature, a major problem in articular cartilage is degeneration of the 
tissue. There is a limited potential to restore cartilage located at the joint surfaces. The 
chondrocytes have a low level of mitotic activity and the tissue is completely avascular. 
An injury to the cartilage can occur in any joint and is referred to as a lesion or defect. 
The most common area of degeneration is the knee, and treatment of this joint is studied 
most often because of its importance for daily human activity. There are two main 
categories of articular cartilage damage: partial thickness defects and full thickness 
- 
defects. An illustration of the two defect types can be seen below in Figure 3 
A: partial thickness defect 
subchondral 
bone 
6: full thickness defect 
Figure 3: Partial Thickness and Full Thickness Defects (Redman et al. 23) 
A defect is defined as partial or full thickness according to the depth it penetrates 
into the marrow spaces of the subchondral bone. Partial thickness defects are analogous 
to the clefts and fissures that are seen in the early stages of osteoarthritis (Hunziker et al. 
72 1). As the stages of osteoarthritis progress, the fibrillated lesions grow larger and 
deeper. These lesions do not heal spontaneously. Many researchers have made the 
assumption that the failure to regenerate is due to the fact that the defect does not 
penetrate the subchondrol bone (bone marrow); therefore, there is no access to the 
progenitor cells in the bone marrow space. In opposition to this idea, it has been proven 
that spontaneous repair of a superficial defect does occur with no fibrous scar and 
restoration of the zonal organization of articular cartilage. Whether or not this repair is 
"true" repair or void filling is still a question that remains unanswered (Redman et al. 23). 
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Often, in mature cartilage, a limited amount of repair does occur within the tissue 
immediately adjacent to the site of the lesion. This process begins with the occurrence of 
cell death in the areas adjacent to the wound. After twenty-four hours have passed an 
increase in cell proliferation and matrix synthesis at this area occurs, but it is short lived 
and there is no actual repair of the defect. Growth factors signals additionally make an 
attempt to heal the defect by inducing cells to migrate across the articular surface from 
the synovium to the lesion, but again fail to do so due to the anti-adhesive properties of 
the proteoglycans (Redman et al. 23). These processes suggest it is not just the absence 
of bone marrow cells that causes incomplete healing of partial thickness defects; instead, 
there are other mechanisms involved that play a role in the inability of the partial 
thickness defects to heal correctly. 
Full thickness defects fully penetrate the subchondral bone and are able to access 
the cells in the bone marrow. The repair response that occurs due to this defect results in 
the formation of a fibrocartilaginous tissue at the site of the defect. In most cases, once 
the subchondral bone is penetrated by the in a full thickness defect, there is immediate 
formation of a hyaline-like articular cartilage. This tissue is an undesirable replacement 
for cartilage and degeneration of both the repair tissue and the native tissue occurs. It has 
been noted in some cases that during this process, the tissue adjacent to the wound 
becomes necrotic and almost no remodeling occurs (Redman et al. 24). Upon 
examination of the full thickness tissue defect, there were many areas of continuity as the 
tissue changed from native to repair tissue, but no true integration was present. Because 
the outcome of both partial and full thickness defects have a lifelong negative effect on 
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the joints, there is a great challenge for tissue engineers to discover a successful way to 
heal articular cartilage defects. 
Osteoarthritis is the number one disease causing articular cartilage damage for 
adults. Avascular necrosis is another condition that can increase the risk of articular 
cartilage degeneration. This disorder involves the death of the bone tissue that lies 
beneath the cartilage as a result of insufficient blood supply. Also, osteochondritis 
dissecans is a condition when the blood supply to a discrete area of the bone is disrupted 
and there is brealung away of fragments of bone and cartilage in the knee. Traumatic 
injury due to sports or accidents of any type can also cause articular cartilage injury. 
Lastly, inflammatory disease, such as rheumatoid arthritis can cause articular damage. 
Current Methods For Treating Articular Cartilage 
There are many methods currently available that attempt to both heal and initiate 
the regeneration of articular cartilage. For minor articular cartilage defects, the abrasion 
technique is utilized to try and rid a small area of loose cartilage pieces. A technique 
called arthroscopy is used, which is when an incision is made at the site of the injury and 
both fiber optics and small instruments are used to clean out any loose particles located in 
the joint. Bleeding is also induced at the bone surface at the site of the wound. 
Fibrocartilage growth is then induced at that area as the body attempts to heal itself at the 
site. The positive aspect of this procedure is that it is brief and does not require the 
patient to be hospitalized. The negative aspect of the procedure is that it does not have a 
very high success rate since the fibrocartilage that is produced at the area of the defect 
may not fully fill the gap and become a durable tissue replacement. Fibrocartilage will 
never be able to function in the same way as native articular cartilage. 
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The next treatment option available for damaged articular cartilage is 
microfracture, which is highly similar to the abrasion method, but with an added step. 
Debridement, which is the act of provoking bleeding, is done at the site of the wound. 
Fibrocartilage is formed, but in addition to clearing away the damaged area, the surgeon 
uses a sharp instrument to make perforations in the bone. The bone marrow contains 
pluripotent cells that have the ability to differentiate into cartilage in t h s  technique, under 
the influence of motion. A continuous passive motion (CPM) machine is often utilized 
by the patient, which allows the knee to repeatedly follow a circular range of motion 
without putting any pressure on the joint. This machine is used following the operation 
for several hours a day. The positive aspect of microfracture is the cheap cost and simple 
procedural steps. Microfracture serves as the best treatment for well-contained lesions 
(Novick Cartilage Regeneration-An Overview). Once again the ability for the 
fibrocartilage to fill the entire gap is questionable and the patient must refrain from 
placing weight on the affected joint for a specified period of time. If fibrocartilage is 
formed at the affected area, the durability of the new tissue will not be that of the native 
tissue. 
Mosaicplasty is a highly talked about technique, which is also referred to as 
osteochondral autograft transplantation (OATS). Both fresh and cadaveric donors are 
used for this method, but research has shown that the fresh tissue is more successful in 
terms of preventing cell death and the ability to achieve mechanical stability (Redman et 
al. 25). Osteochondral transfer is a repair method that is used in the same way as the 
periosteum and perichondriurn grafts that will next be described, but in the next method 
both allogenic and autogenic grafts are used to repair the defective tissue area. 
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Autologous ostechondral grafts involve the removal of plugs of osteochondral tissue 
from a low weight bearing area in the body that is transferred to the debrided defective 
area. Depending on the size of the damaged area, one plug or multiple plugs are utilized. 
This method is usually chosen for small to medium size defects because the larger the 
defect, the larger the risk for rejection (immunologic response). This method is also 
better for patients under the age of 45 with stable joint mechanical alignment (Boland, 
Arthur et al.). An advantage of this techmque is the high survival rate of the 
chondrocytes and the ability of the plugs to maintain the original hyaline cartilage 
characteristics. The disadvantages are morbidity at the site where the plugs are removed, 
the limited supply of tissue available to use as plugs (must be located at a low weight 
bearing area), and the long rehabilitation time that is required (Boland, Arthur et al.). 
Also, it is hard to find any area in the joint that is not bearing any weight, so the smaller 
the defect this technique is used for, the better. There is possibility of chondrocyte death 
around the edges of the plugs that have been implanted, which causes a space to form 
between the graft and the native surrounding tissue. This discontinuity can lead to 
degeneration of the graft over time if cartilaginous tissue (or fibrocartilage) is not formed 
to fill in the gaps. Multiple studies have showed that patients undergoing this treatment 
do show a decrease in pain and an improvement in joint function. 
A technique that is fairly simple and not often used is the removal of a piece of 
the periosteum or perichondnum, which is the connective tissue that covers all bones, 
from a low weight bearing area on the shin. The periosteum/perichondrium is then 
transplanted into the site of the defect. The idea is that there are pluripotent cells located 
in this tissue that lead to cartilage regeneration. Ths  method is used to repair full 
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thickness defects. In experimental trials, a defect is created at the damaged site that is 
- - .  
four mm in diameter. One to two mm of thickness of subchondral bone is removed to 
make room for the insertion of the healthy tissue. The periosteal or perichondrial graft is 
then implanted into the defective cartilage and fibrin glue is used for adhesion. When 
this method was used in a rabbit study, 33% of the cases showed the formation of repair 
tissue that was derived solely from the transplanted periosteum. The other 67% had 
repair tissue that was derived from both the transplanted tissue and the bone marrow 
mesenchymal stem cells (Redrnan et al. 25). Continuous passive motion (CPM) is an 
important factor in the successful healing of the damaged joint when utilizing this 
technique. This procedure does require an overnight visit to the hospital and the result 
can be one of mixed normal and fibrous tissue at the damaged site. 
A highly popular method for natural regeneration of articular cartilage is 
autologous chondrocyte implantation (ACI). Chondrocytes are taken from a healthy area 
of the knee that is not involved in the injury and are implanted at the area of damage. 
Chondrocyte precursor cells from the grafted periosteum and mesenchymal stem cells 
derived from the subchondral bone marrow space are cell sources that can also be 
utilized. The cells are cultured for approximately 14-21 days and then injected into the 
affected area. The entire area is then covered with a sutured periosteal flap that is taken 
from the proximal medial tibia. Brittberg et al. performed a study that involved 16 
patients that were treated with ACI at the femoral joint and seven at the patellar joint and 
followed them for a mean of 39 months. The transplants initially eliminated pain, 
swelling, and locking of the knee for all patients. At the three month mark, all of the 
patients showed that the transplant area was level with the surrounding healthy tissue. 
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The tissue also appeared to have the same spongy (resistant) characteristics as the 
healthy surrounding tissue. After two years, 14 of the 16 femoral ACI patients had good 
to excellent results. The other two patients had to undergo a second operation. The 
results in the patients that underwent patellar ACI were good to excellent in only two of 
the seven patients, fair for three, and poor for two. The two that were rated as poor 
underwent a second operation. There were signs of hyaline cartilage in one of the seven 
patellar ACI patients and eleven of the sixteen femoral ACI patients (Brittberg et al. 892). 
The major advantage of this technique is the possibility of normal hyaline cartilage 
restoration. The disadvantages include the high price, requirement of two separate 
procedures (cell insertion and the adhesion of the flap to cover affected site), and the 
unpredictability of the results for the operation. It has been proven that implanted 
chondrocytes do have the ability to participate in the formation of repair tissue denoted 
by the formation of type I1 collagen and can persist in helping to heal the defect for up to 
14 weeks. 
A method that is a continuation of ACI is the use of a specific chondrocyte 
population taken from an identified area within the articular cartilage that may have 
better replication and integration characteristics in comparison to chondrocytes taken 
from another area. Waldman et al. performed a study which took cells from the full 
thickness, mid and deep zone, and deep zone of articular cartilage. The cells were seeded 
onto calcium phosphate substrates and cultured in vitro. The full thickness chondrocytes 
showed the highest amount of collagen synthesis, but the mid and deep zone 
chondrocytes showed the best mechanical properties and accumulation of proteoglycans. 
If the cells from the mid and deep zone were used to as the implanted cells for ACI, 
- - .  
there would be an improved rate of articular cartilage tissue repair (Redman 28). 
Another method in repairing articular cartilage is the use of a tissue engineered 
scaffold as a tissue substitute to treat the damaged cartilage. When chondrocytes are 
implanted without a scaffold (such as in the ACI technique), they only have the ability to 
synthesize their native ECM proteins, but when the cells are first cultured onto an actual 
scaffold and implanted, the proteins are deposited within the engineered matrix and thus 
have the ability to organize and remodel this structure. When only a cell culture method 
is used, the ECM proteins will just diffuse out into the culture media. The major 
requirements the engineered scaffold must meet are structural integrity, biocompatibility, 
and the correct mechanical stability. The scaffold must be strong enough to support the 
high loads that are placed on the knee and be porous enough to allow synovial fluid to 
flow in and out of the matrix for proper infiltration of the structural molecules. There are 
two major scaffold types: those made from synthetic materials such as polymers and 
those made from natural materials. There are positives and negatives to choosing either 
scaffold material. Scaffolds are three-dimensional and can be formed into a desired 
shape depending on the method of its construction. 
Two highly popular synthetic materials used to create a three-dimensional 
scaffold for the replacement of articular cartilage are poly(glyco1ic acid) (PGA) and 
poly(1actic acid) (PLA) polymers. Tissue engineers often use the materials individually 
or combine them into various combinations such as a copolymer made up of 50% PLA 
and 5O%PGA to form a scaffold that mimics their mechanical requirements. These 
scaffolds are naturally biodegradable and, depending on the method used for the 
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fabrication of the construct, pore size and the fiber diameter can be manipulated. 
- - 
Polymer scaffolds have been shown to equally promote proteoglycan regeneration and 
chondrocyte proliferation, differentiation and maturation in comparison to collagen-based 
scaffolds (Grande et al. 2 13). When utilizing synthetic scaffolds, the need for any donor 
tissue is eliminated and the shape of the scaffold can be coinpletely formed to perfectly 
fit the defective site. The downfall is the risk of rejection from the body. 
There are various methods used to create the synthetic scaffolds for articular 
cartilage replacement. Freed et al. had Acufex Inc. form PGA scaffolds that contained 
12-14 pm diameter fibers forming a non-woven mesh that is 0.1 to 0.2 cin thick with a 
bulk density of 55-65 mg/cm3. The mesh was then cut into 1 cm diameter discs that were 
sterilized and seeded with cells. Freed et al. found that chondrocytes were able to 
proliferate on the PGA scaffold and regeneration of the cartilaginous matrix occurred. 
This study also compared the difference between seeding ,the scaffolds with primary 
chondrocytes, unpassaged chondrocytes and passaged chondrocytes. Defects that were 
filled with all three cell types did have signs of a white colored repair tissue (similar to 
the blush white appearance of native articular cartilage) after one month of in vitro 
implantation. The passaged chondrocytes showed 1.7 times as much GAG production 
and 2.6 times as much collagen production when compared to the scaffolds seeded with 
primary chondrocytes (Freed et al. 891). 
Grande et al. compared the pros and cons of using synthetic and natural scaffolds 
to create tissue engineered articular cartilage. They used PGA to make two min thick 
non-woven fiber mats with a pore size of 200 pm; a PGA-PLA copolymer to make a flat 
woven mesh mat with 2 10 pm pores; and nylon to make flat, square, knitted mesh with 
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90 pm pores. A comparison of the rates of synthesis of proteoglycans and collagen 
were examined for all of the scaffold types. Also, whether or not a bioreactor closed loop 
recirculation system could increase the synthesis of molecular proteins was studied. 
There was a greater rate of proteoglycan synthesis on the polymer scaffolds compared to 
collagen production. The use of the closed loop bioreactor system increased synthesis of 
all molecular proteins for all three scaffolds in con~parison to its absence. This increase 
only occurred initially and did not sustain a difference over a time period of three weeks 
(Grande et al. 21 1). Nylon was the least efficient of the three polymer types. For the 
PLA-PGA blend, the chondrocytes easily attached and replicated in the scaffold, but did 
not transverse into the large pores. Grande et al. stated that when chondrocytes have a 
spindle shape they are not as happy on the scaffold as when they have a spherical 
morphology. For all three polymer scaffolds the cells had a spindle shape, which 
indicates they were not perfectly "happy." 
Grande et al. also compared these three polymer scaffolds to a collagen type I 
bovine fibrillar matrix with a two mm thickness and pore size ranging from 200 to 300 
microns that were also seeded with chondrocytes. The proteoglycan synthesis was 
limited compared to PGA for this scaffold, but the collagen production was higher than 
that of the polymer scaffolds. The cells on the natural scaffold showed a spherical 
morphology, suggesting the scaffold could induce the proper gross phenotypic 
characteristics in the cells, allowing them to attain their natural shape. Grande et al. 
discovered that the proteoglycan synthesis increased at a continuous rate when the 
collagen type I scaffold was cultured in a closed culture system at all the time points 
under observation. 
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In 1997, Nehrer et al. compared sponge-like scaffolds made from type I and 
type I1 collagen for the synthesis of chondrocytes. The type I collagen scaffold was 
constructed from bovine hide using an acetic acid extraction followed by freeze-drying to 
form a porous membrane. The type I1 collagen scaffold was produced by treating porcine 
cartilage to form a three-dimensional sponge-like material with pores that were 
interconnected. The type I1 sponges underwent UV irradiation to cross-link and allow for 
an increase in strength. Both matrices were seeded with chondrocytes in vitro for three 
hours, seven days, and fourteen days. There was a higher percentage of chondrocytes 
with a normal spherical shape for the type I1 matrix at all three time periods. The GAG 
and DNA content increased for all three time points in a larger amount for the type I1 
collagen scaffold compared to the type I collagen scaffold. The type I1 matrix allowed 
for a better site for chondrocyte implantation because it had a higher percentage of 
spherical chondrocytes and there was greater molecular activity for this scaffold as was 
illustrated by the increased rate of GAG and DNA production. This assumption was 
reaffirmed by Pieper et al. in 2001 and Gigante et al. in 2003. 
Pieper et al. followed in Nehrer et al.'s footsteps and compared collagen type I 
and type I1 scaffolds as a site for the implantation of chondrocytes. At first, both the 
bovine Achilles tendon to make the type I scaffold and the bovine tracheal cartilage to 
make the type I1 scaffold underwent an acetic acid extraction. The type I1 collagen did 
not swell properly in the acetic acid; therefore, a pepsin digestion method was utilized. 
Porous type I and type I1 collagen matrices were produced via freezing and 
lyophilization. Pieper et al. also treated some of both scaffolds types with chondroitin 
sulfate to see if cell integration was improved. The matrices were cross-linked and the 
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chondrocytes were seeded in vitro. The matrices were evaluated according to the 
. - - .  
ability of the chondrocytes to proliferate and differentiate. The type I1 collagen scaffold 
provided a better distribution of cells throughout the matrix. Both the type I and type I1 
collagen scaffolds did show a cartilaginous-like layer at the surface and the presence of 
chondrocytes throughout the matrix. The type I1 collagen showed an increase in these 
characteristics in comparison to the type I scaffold, but the addition of chondroitin sulfate 
had no affect on the scaffold quality (Pieper et al. 3 191). 
After both Nehrer et al. and Pieper et al., Gigante et al. compared scaffolds made 
from type I and type I1 collagen for use as a cartilage replacement. The type I collagen 
scaffold was made from equine tendons that were put through an acid extraction process. 
After stringent purification techniques were performed and the acetic acid was removed, 
the material was lyophilized and formed as films in dies that were contained in an 
electrostatic field. The collagen type I1 scaffold was made from porcine samples that 
were processed the same exact way as those made from the equine tendon, except HC1 
was used for the acid extraction instead of acetic acid. The scaffolds were seeded with 
chondrocytes and the cell morphology was studied in order to decide which scaffold 
allowed for a conducive environment. On the type I collagen matrix, the cells held an 
elongated shape and formed a layer of only one to two cells thick on the membrane 
surface. The cells on the collagen type I1 matrix were spherical in shape that were 
several cells thick on both the membrane surface and penetrating through the scaffold 
(Gigante et al. 714). 
The latest technology that is under investigation is the use of stem cells that are 
derived from tissue sources other than articular cartilage. Stem cells have the ability to 
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self-renew and morphologically change according the environment into which they are 
implanted. Stem cells will spark both regeneration and repair in a desirable manner that 
is required by the tissue at the site they are implanted when damage occurs. 
Mesenchymal stem cells taken from bone marrow are currently being considered. These 
cells can then be used in the ACI method previously described or grown on a scaffold and 
inserted into the body. 
Overall, the use of a scaffold, whether natural or synthetic, has proven to give the 
best results when implanted into the body to encourage cartilage regeneration. If the 
scaffold is composed of collagen type 11, which is the material making up the majority of 
the articular cartilage tissue, a high degree of reproducibility is not guaranteed, but has 
shown better results in comparison to scaffolds made from type I collagen. Polymers are 
usually manufactured with hgh  reproducibility and can be molded into nearly any shape. 
The degradation rate of the polymer can be easily controlled, but this scaffold type has an 
increased risk of rejection from the body. It is common sense to assume that the body 
would be more accepting of a natural material. The cells would more easily adapt and 
regenerate in its natural environment. A blend of natural and synthetic materials to make 
a scaffold would be potentially advantageous because the body would easily accept the 
scaffold because of the natural material, but the polymer material would increase the 
strength, integrity, and reproducibility of the scaffold. An improvement for the actual 
construction method of the scaffold is the major area that needs improvement. 
Electrospinning Background 
Electrospinning is a method of creating a micro to nano-fibrous non-woven mat 
that was first utilized in 1934 by Anton Formhals (Forrnhals 1) who was granted a patent 
to use this idea to spin a cellulose ester solution. Next, William Huebner (Huebner 1) 
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received a patent that allowed him to utilize the method of electrospinning to spin sheets 
or webs. Both patents utilized this technology to form continuous sheets of material for 
commercial use. 
A high voltage power supply, ground and source electrodes, a dissolved solution 
to be spun, and a grounded collection surface are the required equipment for 
electrospinning. The electrospinning system requires a charged solution that can be 
either a natural or synthetic material that is dissolved in a solvent. Electrospinning 
requires that a fluid jet be subjected to a highly charged electric field with little or no 
current present. The jet is drawn out of the syringe at a set speed, which is dependant 
upon the material that is being electrospun. As the fluid jet leaves the needle tip, the 
solvent evaporates and a dry single fiber is formed that whips around in the air between 
the needle tip and the collecting plate (mandrel). A grounded surface, referred to as a 
mandrel, is located at a distance from the charged solvent creating an electric field. The 
fibers wrap around this surface to from a porous sheet of fibers. The shape and size of the 
collection plate is completely dependant on the desired use of the mat. A diagram of the 
electrospinning process can be seen below in Figure 4. . 
Collutlon T m e t  
Elmrlc Field 
Figure 4: Diagram of Electrospinning Apparatus 
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Collagen Type 11 Extraction 
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Type I1 collagen is the main constituent that makes up cartilage ECM, so this 
material was chosen for use in this experiment. There are various sources that can be 
used to extract type I1 collagen. Pieper et al. extracted type 11 collagen from bovine 
tracheal cartilage via pepsin digestion. Various dialyses were performed on the material 
to assure purity and the final form of the material was reached after lyophilization. 
Herbage et al. used the same extraction method but instead of using bovine tracheal 
cartilage, bovine patellar articular cartilage was used. Gigante et al. extracted type I1 
collagen from porcine trachea using HCl for the extraction procedure. Films were then 
formed in dies from this material with the use of electrostatic charge. Nehrer et al. also 
extracted type 11 collagen from porcine cartilage, but the end product was a sponge-like 
material with the use of lyophilization. Three groups of researchers: Edward Miller, 
Trentham et al. and Von Der Mark et al. utilized chick cartilage to extract type I1 
collagen. A SDS-Page was used to identi@ the level of purity of the type I1 collagen and 
to check for any type I collagen contamination. Because bovine samples are the most 
readily available, this was the material utilized for the extraction process in our 
experiment. The largest amount of type I1 collagen is found in the patellas of bovine 
specimens in comparison to other test animals including rats, chicks, or porcine 
specimens. The age of the cartilage chips that will yield the greatest amount of material 
is also in question. Our study compared the type 11 collagen found in fetal cartilage chips 
and two groups of patellas from bovine samples that are 140-1 80 days old. 
The electrospinning of type I1 collagen is novel, and will produce a material that 
has fibers which resemble that of the native tissue fibers. The material will be natural 
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and completely composed of type I1 collagen, which makes up 90% of the total 
collagen content in cartilage. This material should be easily accepted by the body 
without the risk of rejection and can be formed into any shape for implantation. The 
yield of the extraction for the three groups of cartilage chips will be examined along with 
the characteristics of the electrospun scaffolds. 
Materials and Methods 
This project was undertaken to discover the different end amounts of type I1 
collagen that can be extracted from the cartilage chips of different age bovine specimens. 
It will also be determined whether or not the purity of the end product of collagen type I1 
is affected according to whether or not there are remnants of blood vessels or bone 
marrow present in the chips. If the extraction of collagen type I1 from the cartilage chips 
is successful, it is desirable to discover if collagen type I1 can be electrospun into 
scaffolds that have the ability to be tailored to the use of interest. The properties of the 
electrospun scaffolds should be evaluated according to pore size and fiber diameter at the 
concentrations of 0.06,0.08,0.10, and 0.12 g collagen type I1 /mL HFP for the three 
bovine groups. 
The protocol utilized for the collagen type I1 extraction was donated by Dr. David 
Brand. He also donated the fetal cartilage chips for the study. The cartilage from all of 
the fetal bovine joints were utilized for the extraction of the type I1 collagen. Cartilage 
chips were purchased from Lampire Biologics (Pipersville, PA), which contained 
fragments of bone marrow and blood vessels. The age of the cows utilized for these 
chips was 140-180 days old and only the patellar joint was utilized. Whole patellas were 
purchased from Spear Products (Quakertown, PA) within the same age groups as the 
chips from Spear Products. The articular cartilage was manually scraped from .the Spear 
Products patellar surfaces with the use of a scalpel. Only the clear hyaline surface was 
2 5 
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used to create the chps, leaving no blood vessel or marrow contamination when the 
- -. 
type I1 collagen was extracted. The following section describes the steps followed to 
extract collagen type I1 from the cartilage groups. 
Extraction of Type II Collagen 
1. Cartilage chips from the ends of all joints of fetal bovine specimens were obtained 
from Dr. David Brand. Bluntly pre-cut cartilage chips from bovine patellas were 
obtained from Larnpire Biologics that were slightly contaminated with fragments 
of bone marrow and blood vessels (140-1 80 days old). Whole patellas from 
calves (140- 180 days old) were obtained from Spear Products and the hyaline 
cartilage surface was scraped off creating cartilage chips with no contamination 
(completely clean chips). Below is a picture of each of the three cartilage chlp 
groups used for the experiment. 
I. 
Figure 5: Lampire Cartilage Chips 
Figure 6: Spear Cartilage Chips 
Figure 7: Fetal Cartilage Chips 
2. The weight of the cartilage chps was obtained for each batch, and the chips were 
cut into smaller pieces with a razor blade. The cutting tray was set over a bucket 
filled with ice in order to keep the cartilage from reaching a temperature over 4°C. 
A Waring CB15 three horsepower blender was used to blend the chips with 
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deionized water (Barnstead International combination organic 
removal/ultrapure filter #D8922) and ice to macerate them into the smallest size 
possible. For every 100 grams of material that was put into the blender, a 
combination of approximately one liter of ice (equal to 500 mL of water) and 500 
mL of deionized water was added. The blender underwent three pulses at the 
maximum setting for the duration of one minute each. Between each pulse, the 
lid was removed and the material was wiped down from the sides to assure all the 
material was blended. 
3. A volume of cold (4°C) 5 M guanidine (Sigma Aldrich #G4505) that was made to 
have a pH of 7.4 with the addition of 0.05 M Tris (VWR buffer Tris pH 7.50 
#VWR873 1-1) was added in an equal volume amount to the blended mixture. 
The guanidine removed the proteoglycans. For example, if the batch were 100 
grams, one liter of ice and 500 mL of deionized water would be added to the 
blender. The guanidine solution, with a pH of 7.4, would be added to this 
solution in the amount of 750 mL. The addition of these solutions to the blended 
cartilage pieces was done in a seven liter bucket (Nalgene #7012-0800) for a 
starting solution that was smaller than two liters or a 13 liter bucket (Nalgene 
#7012-0140) for a starting solution that was over two liters. The bucket sat on a 
stirring plate (Corning heavy duty stirrer #PC-61 1) with a magnetic stir bar (VWR 
polygon magnetic stir bar 70 mm x 10 mm #VW873 1-1) at the bottom of the 
bucket stirring at the setting of seven. The solution was then placed in a 
refrigerator (4°C) or cold room (4°C) to stir overnight. 
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4. The mixture was then put into a Beckman Coulter Avanti J-20 XP centrifuge 
- - .  
(JLA 8.100 rotor, 6 slots with a volume of 1000 mL each, 20" angle) at 8336 g 
(6000 RPM) for 30 minutes. The centrifuge was set to a temperature of 4°C. The 
supernatant was discarded and the deionized water was added to the cartilage 
pellet in a volume equal to the starting volume from step #2 (1500 mL for the 
example explained in step #3). The cartilage chips and deionized water stirred in 
the cold room for one hour to wash the pellet. The addition of the deionized 
water to the cartilage and the stirring of the material were done in the same 
manner as the stirring set up that was described in step #3. 
5. The cartilage pellet was then again centrifuged in the Beckman Coulter Avanti J- 
20 XP centrifuge at 8336 g at 4°C for 30 minutes. The pellet was washed and 
centrifuged a minimum of three times. The reason for so many repeated washings 
of the pellet was to assure all of the guanidine was completely removed before 
moving on to the next step. 
6. After the last wash was completed, the pellet was suspended in a volume of 0.5 M 
acetic acid (HAc) (Fisher Scientific #UN2789) that was equal to the amount of 
deionized water that was added for washing the pellet (1500 mL for the example 
batch). Thls was done by removing the pellet from the centrifuge tubes with a 
spatula and adding it to the 0.5 M HAc and stirring the solution in a manner 
identical to that described in step #3. The pH of the stirring solution was then 
adjusted to 2.8 with the addition of formic acid (Sigma Aldrich #F0507). 
7. Pepsin (Sigma Aldrich #P-6887) was then added to the solution in an amount of 
one gram per one liter of solution. The needed amount pepsin was first dissolved 
3 0 
in a small amount of cold distilled 0.5 M HAc (approximately 3 mL 0.5 M HAc 
- - .  
per gram of pepsin). This was then immediately added to the stirring (stirring set- 
up described in step #3) cartilage homogenate. If the pepsin solution was not 
added quickly, it would autolyze in the acetic acid solution. 
8. The solution was then mixed with tall electric stirrer that entered into the liquid 
from the top of the bucket (Arrow Engineering Company, Inc #850) via a ring 
stand (Caframo #A210) that could be adjusted according to the height of the 
bucket at 4OC in the cold room or refrigerator overnight. The homogenate was 
viscous with minimal cartilage pieces the within 24 hours. 
9. The homogenate was then centrifuged in a Beckman Coulter Avanti J-20 XP at 
8336 g for 60 minutes at 4OC. The supernatant then contained the solubilized 
type I1 collagen and the pellet could either be discarded or another pepsin 
extraction could have been performed at this point. 
10. Ten milliliters of 1 M Tris was added for every liter of supernatant collected. The 
pH of the sol~~tion was then brought to 7.4 with the use of 10 M NaOH (VWR 
#VW3247-I). An equal volume of 5 M NaCl (Fisher Scientific #S640-500) was 
then added to the solution at a very slow rate while the solution was constantly 
stirred. The addition of both the 10 M NaOH and the 5 M NaCl was done while 
the solution stirred in the manner described above in step #3. The solution was 
then left out at room temperature for 24 hours. A cloudiness was observed in the 
solution after the 24 hours passed. 
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11. The collagen precipitate was then collected by centrifugation in the Beckman 
Coulter Avanti 5-20 XP at 8336 g for 60 minutes at 4OC. The pellet was collected 
and the supernatant was discarded. 
12. The pellet was put into a solution of 0.05 M Tris that was equal to the beginning 
volume from step #2 (water and ice volume combined). 0.2 M NaCl was then 
added to adjust the pH to 7.4. The pellet was dissolved (stirred as described in 
step #3) in this solution for 24 hours at 4°C in the cold room or refrigerator. A 
dialysis (dialysis membrane tubing, MWCO 12,000 to 14,000 Daltons, Fisher 
Scientific #08-667E) was then performed on the material against the same buffer 
the pellet was dissolved in for two total changes, once every 24 hours, at 10 times 
its volume. The dialysis tubing utilized had a flat width of 45 mm, diameter of 29 
mm, and a volume/length of 6.4 mL/cm. The tubing was cut into lengths of two 
feet and filled with the material and knotted at the ends. A maximum of three 
tubes were placed in each of the 13 liter buckets. 
13. The dialyzed material was centrifuged in the Avanti 5-20 XP at 8336 g for 60 
minutes. The supernatant was collected and the pellet was discarded. 
14. 500 g of DE 52 (Whatman #4057200) was added to the supernatant and was 
stirred (described in step #3) at 4OC for 24 hours. 
15. The solution was centrifuged in the Avanti J-20 XP at 8336 g for 30 minutes at 
4"C, and the supernatant was kept. 
16. The correct volume of 5 M NaCl was added to the supernatant to make the 
solution have a final concentration of 0.8 M NaC1. Also, the correct volume of 
HAc was added to the solution to make the final concentration 0.1 M HAc. The 
solution was then stirred (described in step #3) at 4°C for 24 hours to 
precipitate the collagen. 
17. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at 
4°C and the supernatant was discarded. 
18. The collagen pellet was then dissolved in a volume of 0.1 M acetic acid that was 
equal to the original volume in step #2. The solution was stirred (described in 
step #3) at 4°C for 24 hours. 
19. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at 
4°C and the supernatant was collected. The supernatant was then placed in 
dialysis tubing (Fisher Scientific #08-667E) and dialyzed against 0.01 M 
Na2HP04 (Sigma Aldrich #S-9638) at a volume of ten times that of the solution in 
the tubing (described in step # 12). The dialysis stirred (described in step #3) at 
4°C and the buffer was changed a total of four times (once every 24 hours). The 
collagen precipitated in this step. 
20. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at 
4°C the pellet was dissolved (discard the supernatant) in a volume of 0.1 M HAc 
that equal to the volume used in step #18. The solution was stirred (described in 
step #3) at 4°C for 24 hours to assure that the pellet was completely dissolved. 
2 1. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at 
4°C and the supernatait was collected. The supernatant was then placed in 
dialysis tubing (described in step #12) and dialyzed against 0.01 M HAc at a 
volume of ten times that of the solution in the tubing. The dialysis was stirred 
3 3 
(described in step #3) at 4OC and the buffer was changed a minimum of six 
- - 
times (once every 24 hours). 
22. This material was then taken out of the dialysis tubing and poured into a 
traditional ice cube trays (16 cubes per tray with the dimensions of 4 cm x 3 cm x 
3 cm) and frozen in a Forrna Scientific -20°C freezer for 24 hours. 
23. The frozen cubes were then put into 200 mL lyophilization jars, at a maximum of 
four cubes per jar, and the material was lyophilized using a Labconco Freezone 
4.5 freeze drying machine until it reached a fluffj white cotton ball consistency. 
24. This freeze dried material was weighed and stored at -20°C 
25. The end weight of the lyophilized type I1 collagen for all three groups was then 
compared to the beginning weight of the cartilage chips in order to calculate the 
actual yield. 
SDS Page of Type I1 Collagen to Check for Purity 
Once the collagen was extracted for the three cartilage chip groups, a purity test is 
required to assure the end product is actually clean collagen type I1 without other 
contaminants. A SDS-Page was chosen to check the quality of the extracted material 
against a collagen type I and type I1 standard that was obtained from Dr. David Brand. 
The following steps describe the protocol that was utilized. 
1. To check for purity, the extracted collagen type I1 was dissolved at a 
concentration of four pg/yL in 0.0 1 HAc. A 10% Pierce Endogen 12 well gel 
was utilized (Pierce Endogen product # 2522 1) for the following procedure. 
2. Twenty microliters of the dissolved collagen solution was placed into a 1.5 mL 
microcentrifuge tube (Fisher Scientific #05-406-16). An equal part of the 
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denaturing buffer was added. The buffer chosen was composed of 50 yL of P 
mercaptoethanol (BME) (BioRad # 16 1-07 10) and 950 yL Laemmli sample buffer 
(BioRad product # 16 1-0737). 
3. Step #2 was repeated for both the collagen type I and type I1 standard that had the 
same concentration of four ygipL. 
4. All samples were then boiled for five minutes on a Thermolyne Nuova I1 stir plate 
at a heat setting of 10. 
5. All samples were placed in a microcentrifbge (Fisher Scientific Micro 16) at 100 
g for five minutes. 
6. The gel was then placed in the gel holder (BioRad Mini-Protean I1 Cell model) 
and properly aligned by loosening all the screws and assuring the gel was in 
place. The screws were tightened and this set-up was referred to as a rig. Two 
gels must be run at once, forming an inner chamber between the two. 
7. The rig is then placed into the bucket and the inner chamber of the rig was filled 
with running buffer, which is composed of one packet of BupH Tris-HEPES-SDS 
running buffer (BioRad #161-0790) dissolved in 500 mL of distilled water. It is 
important that there were no leaks present. 
8. Each well in the gel was then flushed with a 20 pL of the running buffer. A long 
0.1 to 10 yL long reach pipette tip (VWR #82028-534) was used to push the 
buffer into each well and then to remove the buffer. 
9. The outside of the chamber (area between the outer rig area and the bucket) was 
then filled with the running buffer at a height of approximately two inches. 
10. The samples were loaded into each well at a volume of 40 yL. 
1 1. The correct lid was placed on the SDS-gel apparatus (BioRad Mini Proten I1 
Cell model) and the gel was run at an amplitude of 230 and a voltage of 140 
(BioRad power supply 10001500 model). The gel was nln until the dye ran off of 
the plate, which took approximately 60 minutes. 
12. The gel was then taken off of the gel plate and the teeth of the wells where the 
material was pipetted into the gel was removed in order to form a perfect 
rectangular gel. 
13. The gel was then placed in a box with the dimensions of 22.5 cm x 22.5 cm x 5 
cm (Nalgene #5705-2020) allowing it to be covered with coomassie blue (BioRad 
# 16 1-0435) and shaken on an orbital shaker for one hour. 
14. The gel was then rinsed with water multiple times in a highly gentle fashion or the 
gel will tear. 
15. The gel shook in deionized water for a few hours up to 24 hours. The gel was 
stored in this fashion until an image was taken of the gel. 
16. A picture was taken of the gel within two days using a BioRad Gel Doc 2000. 
17. The extracted type I1 collagen from the three groups was compared to the 
collagen type I and type I1 standards. This allowed for the discovery of any type I 
collagen contamination and for the comparison between the type I1 standard and 
the extracted type I1 collagen banding pattern. 
Electrospinning of Type LI Collagen 
Once the extracted type I1 collagen was proven to have a desirable level of purity, 
the material was electrospun into scaffolds from solutions with the desired concentrations 
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of 0.06, 0.08, 0.10, and 0.12 g h L  HFP. The following steps describe the procedure 
that was followed when forming the various scaffolds. 
1. If there was no collagen type I contamination and the collagen type I1 standard 
matched the extracted type I1 collagen banding pattern, the lyophilized extracted 
type I1 collagen was then dissolved in HFP ( 1,1,1,3,3,3, hexafluoro-2-propanol 
Sigma # 105228) at the concentrations of 0.06,0.08, 0.10, and 0.12 g/mL HFP. 
Because the process during the first collagen type I1 extraction had many errors, 
the yields of the groups were very small. The concentrations utilized to 
electrospin the extracted material from the three groups was quite different. For 
this group, the fetal cartilage chip group was electrospun at the concentrations of 
0.05, 0.06, 0.07, 0.08, 0.09,0.10, 0.1 1,0.12,0.13, 0.14, and 0.15 g/mL HFP; the 
Spear material was spun at 0.04 and 0.06 g/mL HFP; and the Lampire group was 
spun at 0.08, 0.10, and 0.12 g/mL HFP. 
2. The SEM pellet was utilized as the grounded mandrel. The pellet was taped onto 
a rectangular (3 cm x 1 cm) mandrel that was set at a distance of 3.5 in. from the 
needle tip. The RPM at which the mandrel spun was approximately 800 and the 
applied voltage was 20 kV with minimal current present. The viscosity and 
appearance of the solution should be noted. 
3. The dissolving of the collagen type I1 into the HFP at the proper concentration 
was done in a vial (VWR # 15-425). The solution was drawn out of the vial with a 
five inL syringe (Becton Dikinson #309603) and a blunt needle tip (Becton 
Dikinson 18 guage 1.5 short bevel #305 199) was attached to the end of the 
syringe. 
4. The syringe with the needle tip was then placed on a syringe pump (KD 
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Scientific #loo) that was set to dispense the fluid at the speed of 2 mL/hr and a 
banana clip attached to the 20 kV power source (Spellman #CZEOPNl 00) was 
connected to the needle tip. 
5. The solution was then drawn out of the syringe as a single fiber that collected 
onto the grounded spinning mandrel1SEM pellet. Below is a picture of the actual 
apparatus that was used for this experiment. 
6. The SEM pellet was removed from the mandrel and kept in order to take SEMs of 
the material. 
7. The SEM pellets were dry gold coated with a sputter coater from Electron 
Microscopy Sciences. 
8. SEMs were taken of each of these scaffolds at the four concentrations (or more 
for the first extraction) for the three different patella groups using a Joel 820 
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Scanning Electron Microscope (Jeol LTD, Tokyo, Japan) at a magnification 
ranging from 500X to 4000X. 
9. ImageTool3.0 (University of Texas Health Science Ceneter, San Antonio, TX) is 
an image processing and analysis program for displaying, editing, and analyzing 
grey scale images that was used to measure the fiber diameter and pore size of 
each concentration for each of the patella groups at all concentrations. 
10. Using ImageTool3.0, the fiber diameter of each picture was measured using a 
point-to-point method at 60 measurements per picture. One point was started on a 
side of the fiber that measured the perpendicular distance to the other side of the 
fiber. For pore size, the same program and method was used, but the distance that 
existed between the fibers was measured from all angles at a total of 60 
measurements per picture. 
Statistical Analysis 
The statistical analysis of the results for the comparison of the percent yield of the 
three cartilage groups and both the fiber diameter and pore size for the various 
concentrations of the electrospun mats was done utilizing Tukey's method. JMP Version 
5.0.1.2 is statistical discovery software designed by SAS Institute, Inc. that was used to 
determine the comparison of the significant difference(s) of the results that were under 
analysis. 
Results 
Yield for the First Extraction 
Below, in Figure 9, the percent yield results for the first extraction can be seen. 
The fetal group had the highest percent yield of 0.67%; the Lampire group had a percent 
yield of 0.08%; the Spear group had a percent yield of 0.06%. 
Cartilage Chip Age (Source) va % Yield Type II Collagen 
Fetal (Dr.Brand) 140-180 Days Old 140-180 Days Old (Spear) 
(Larrpire) 
Cartilage Chip Age (Source) 
Figure 9: Percent Yield of Extracted Collagen Type I1 for Fetal, Lampire, and Spear 
Cartilage Chip Groups 
Purity Results for the First Extraction 
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Below, in Figure 10, a SDS-Page was performed for all three groups and both a 
collagen type I and type I1 standard. It is visually apparent that the banding pattern for 
the fetal and Lampire cartilage chip groups match that of the collagen type I1 standard 
and not that of the collagen type I standard suggesting the presence of type I1 collagen. 
The Spear cartilage group does show a lighter banding pattern that is similar to that of the 
collagen type 11 standard, but it is much lighter in color and a bit harder to read 
suggesting there may have been an issue of concentrationlcontamination. 
Figure 10: SDS-Page for Fetal Bovine Patella Chips, Spear Bovine Patella Chips, and 
Lampire Bovine Patella Chips 
Electrospinning Results for the First Extraction 
When electrospinning the scaffolds for the first extraction, an 18 gauge syringe 
needle was used, the voltage was set to 20 kV with minimal current, the mandrel spun at 
approximately 800 RPM, and the needle was 3.5 inches away from the mandrel. Due to 
lack of material, the fibers were directly spun onto a SEM pellet that was attached to the 
spinning mandrel (same electrospinning parameterslmethod was used for the 
electrospinning in extraction two and three). The concentrations chosen for the 
electrospinning of the scaffolds for the three groups was inconsistent for the initial run 
because it was the first time the material had been extracted and dissolved in HFP. The 
fetal cartilage group had the highest yield and it also was easily electrospun at low and 
high concentrations. Because of this, the material was electrospun at the following 
eleven concentrations: 0.05, 0.06, 0.07,0.08, 0.09, 0.10, 0.1 1, 0.12, 0.13, 0.14, and 0.15 
g/mL. The Spear material electrospun at the lower concentrations of 0.04 and 0.06 g/mL, 
but was too thick to be electrospun when the concentration was increased. The Lampire 
material was electrospun at 0.08,O. 10, and 0.12 g/mL. This material was not viscous 
enough to be electrospun when dissolved at the lower concentrations. This was the first 
time the material was manipulated for electrospinning, so it was a matter of trial and error 
to figure out the best concentrations for spinning of the material. The fact ,that there was 
such a small amount of material made the task even more difficult. 
Figure 11: SEM of 0.05 g/mL, Collagen Type 11 (Fetal Bovine Cartilage Chip) 
Figure 12: SEM of 0.06 g/mL Collagen Type 11 (Fetal Bovine Cartilage Chip) 
Figure 13: SEM of 0.07 g/mL Collagen Type I1 (Fetal Bovine Patella Chlp) 
Figure 14: SEM 0.08 g/mL Collagen Type I1 (Fetal Bovine Patella Chlp) 
Figure 16: SEM 0.10 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chips) 
Figure 18: SEM 0.12 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip) 
Figure 19: SEM 0.13 g/mL Collagen Type I1 (Fetal Cartilage Patella Chip) 
Figure 20: SEM 0.14 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip) 
Figure 21: SEM 0.15 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chlp) 
Figure 22: SEM 0.04 g/mL Collagen Type I1 (Spear Bovine Patella Chp) 
Figure 23: SEM 0.06 g/mL Collagen Type I1 (Spear Bovine Patella Chip) 
Figure 24: SEM 0.08 g/mL Collagen Type I1 (Lampire Bovine Patella Chp) 
Figure 25: SEM 0.10 g/mL Collagen Type I1 (Lampire Bovine Patella Chip) 
Figure 26: SEM 0.12 g/mL Collagen Type II (Lampire Bovine Patella Chip) 
- 
Fiber and Pore Measurement for the First Extraction 
The data that was utilized to create the graphs in the figures 27 and 28 seen 
below, the statistics for both the fiber diameter and pore size can be calculated. Using the 
Tukey's W procedure, the values for the mean fiber diameter are significantly different 
between all concentrations for the fetal cartilage chip group except 0.05 and 0.06,0.08 
and 0.06,0.07 and 0.08,O. 14 and 0.1 1 and 0.12 g/rnL. The values for fiber diameter 
were all significantly different for the Lampire and Spear group. When analyzing pore 
size, the fetal cartilage chip group utilizing Tukey's W procedure the values were all 
significantly different except 0.06 and 0.07,0.06 and 0.08,O. 10 and 0.1 1 and 0.12 g/mL. 
For the Larnpire and Spear groups, the pore size values were all significantly different. 
These values were all calculated with a = 0.05. 
Fiber Diameter for Type II Collagen Extraction #I 
Concentration (g type II colllmL HFP) 
Lampire 
Figure 27: Fiber Diameter Comparison Results for Collagen Type I1 Extraction # 1 
Pore Size Results for Collagen Type I1 Extraction #1 
Pore Size for Collagen Type II Extraction #I 
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Figure 28: Pore Size Results for Collagen Type I1 Extraction #1  
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Yield Results for the Second Extraction 
Below, in Figure 29, the percent yield results for the second extraction can be 
seen. The Spear group had the highest percent yield of 0.045%; the Larnpire group had a 
percent yield of 0.031%; the fetal group had a percent yield of 0.014%. 
Cartilage Chip Age(Souroe) va %Yield Type I1  Collagen 
Fetal (Dr.Brand) 140-180 Days Old 140-180 Days Old (Spear) 
(Lamre) 
Cartilage Chip Age (Source) 
Figure 29: Percent Yield of Extracted Type I1 Collagen for Fetal, Lampire, and Spear 
Cartilage Chip Groups 
Purity Results for the Second Extraction 
There are no purity results for the second run. The liquid material from the last 
dialysis did not have a collagen concentration high enough to show a banding pattern 
when the SDS-Page was performed. There was not enough material to make an attempt 
to spin the material and to dissolve material for an SDS-Page. Because actually 
electrospinning the material is the first priority, the small amount of lyophilized end 
material was used for the attempt to spin the material from the three batches. 
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Electrospinning Results for the Second Extraction 
Again, for this run, the electrospinning results were inconsistent due to the small 
amounts of material that were extracted from the three groups. The ideal concentrations 
were electrospun (0.06,0.08,0.10, and 0.12 g/mL), but only the Lampire bovine cartilage 
chip group gave a yield of lyophilized collagen type I1 material in an amount large 
enough for the electrospinning procedure. There were still errors present in the 
procedure. 
Figure 30: SEM 0.06 g/mL Collagen Type I1 (Lampire Bovine Patella Chip) 
Figure 31: SEM 0.08 g/mL Collagen Type 11 (Lampire Bovine Patella Chip) 
Figure 32: SEM 0.10 g/mL Collagen Type I1 (Lampire Bovine Patella Chip) 
Figure 33: SEM 0.12 g!mL Collagen Type I1 (Lampire Bovine Patella Chip) 
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Fiber and Pore Measurement for the Second Extraction 
Utilizing the values used to create the graphs below in Figures 34 and 35, the 
statistics for fiber diameter and pore size can be calculated. Using the Tukey's W 
procedure with a a = 0.05, the values for the mean of all concentrations for the fiber 
hameter and pore size for the second run of the collagen type I1 extraction were 
significantly different. 
Fiber Diameter for Collagen Type II Extraction #2 
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Figure 34: Fiber Diameter Results for Collagen Type I1 Extraction #2 
Pore Size for Collagen Type II Extraction #2 
0.06 0.08 0.1 
Concentration (g Type II  ColllmL HFP) 
Figure 35: Pore Size Results for Collagen Type 11 Extraction #2 
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Yield Results for the Third Extraction 
Below, in Figure 36, the percent yield results for the third extraction can be seen. 
The Spear group had the highest percent yield of 0.64%; the Lampire group had a percent 
yield of 0.18%; the fetal group had a percent yield of 0.14%. 
Cartilage Chip Age(Source) v9 %Yield Type II Collagen 
P 
S Fetal (Dr.Brand) 140-180 Days Old 14&180 Days Old (Spear) 
(Lamre) 
Cartilage Chip Age (Source) 
Figure 36: Percent Yield of Extracted Collagen Type I1 for Fetal, Larnpire, and Spear 
Cartilage Chlp Groups 
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Purity Results for the Third Extraction 
When analyzing the SDS-Page below in Figure 37, it is visibly apparent that the 
banding pattern for all three of the cartilage chip groups matches that of the collagen type 
I1 standard. This allows us to conclude that the extracted type I1 collagen has a high level 
of purity. The banding pattern for the three groups does not match that of the type I 
collagen standard, suggesting that there is little type I collagen contamination. 
Figure 37: SDS-Page for Fetal Bovine Patella Chips, Spear Bovine Patella Chips, and 
Lampire Bovine Patella Chips 
. 
Electrospinning Results for the Third Extraction 
For this final run, all three groups were electrospun at the four desired 
concentrations of 0.06, 0.08,O. 10, and 0.12 g/mL HFP and a comparison of the scaffold 
characteristics was possible. 
Figure 38: SEM 0.06 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip) 
Figure 39: SEM 0.08 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chips) 
Figure 40: SEM 0.10 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip) 
Figure 41: SEM 0.12 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip) 
Figure 42: SEM 0.06 g/mL Collagen Type I1 (Spear Bovine Patella Chip) 
Figure 43: SEM 0.08 g/mL Collagen Type I1 (Spear Bovine Patella Chip) 
Figure 44: SEM 0.10 g/mL Collagen Type I1 (Spear Bovine Patella Chip) 
Figure 45: SEM 0.12 g/mL Collagen Type 11 (Spear Bovine Patella Chip) 
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Figure 46: SEM 0.06 g/mL Collagen Type I1 (Lampire Bovine Patella Chip) 
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Figure 47: SEM 0.08 g/mL Collagen Type I1 (Lampire Bovine Patella Chip) 
Figure 48: SEM 0.10 g/mL Collagen Type I1 (Lampire Bovine Patella Chip) 
Figure 49: SEM 0.12 g/mL Collagen Type I1 (Larnpire Bovine Patella Chip) 
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Fiber and Pore Measurement for the Third Extraction 
Utilizing the data used to create the graphs below in Figures 50 and 51, the 
statistics for the fiber diameter and pore size can be calculated. Using the Tukey's W 
procedure with an a = 0.05, the values for the fiber diameter for the Lampire, Spear and 
fetal cartilage chip groups at all concentrations are all significantly different from one 
another withn each group. When analyzing the pore size for each of the groups in the 
same manner, the values for the Larnpire and fetal cartilage chlp groups are all 
significantly different fiom one another at all concentrations. For the Spear group, the 
values are all significantly different from one another except for the concentrations of 
0.06 and 0.08 g/mL, whlch are not significantly different. 
Fiber Diameter for Collagen Type II Extraction #3 
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Figure 50: Fiber Diameter Results for Collagen Type I1 Extraction #3 
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Figure 51: Pore Size Results for Collagen Type I1 Extraction #3 
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Overall comparison for all extractions for fiber diameter and pore size 
The following graphs in Figures 52 thru 57 visually show how the fiber diameter 
and pore size compare to one another for the three extractions. For the fetal and Spear 
groups, there will only be two extraction groups for comparison of both fiber diameter 
and pore size because the second extraction only yielded material for the Lampire group. 
Fiber Diameter for Extraction #I vs. #3 (Fetal) 
1 + Extraction #l / 
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Figure 52: Fiber Diameter Comparison for Fetal Cartilage Chips 
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Figure 53: Fiber Diameter Comparison for Lampire Cartilage Chips 
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Figure 54: Fiber Diameter Comparison for Spear Cartilage Chips 
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Figure 55: Pore Size Comparison for Fetal Cartilage Chps 
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Figure 56: Pore Size Comparison for Lampire Cartilage Chips 
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Figure 57: Pore Size Comparison for Spear Cartilage Chips 
Statistical Analysis 
Below, in Figure 58, the Tukey procedure with an a = 0.05 is used to assess 
whether the Lampire, Spear, and fetal cartilage chip groups are significantly different 
from one another according to fiber diameter. It was determined that the Spear group is 
significantly different from the Lampire and fetal groups in terms of fiber diameter. The 
Lampire and fetal cartilage chip groups are not significantly different from one another. 
Below, in Figure 59, the Tukey procedure with an a = 0.05 is used to assess 
whether the Lampire, Spear, and fetal cartilage chip groups are significantly different 
from one another according to pore size. The same relationship exists for the pore size as 
the fiber diameter. The Spear group is significantly different from both the fetal and 
Lampire groups. The fetal and Lampire cartilage chips groups are not significantly 
different from one another in terms of pore size. 
When analyzing the different concentrations for all three groups combined 
according to the fiber diameter using the Tukey's procedure with an a = 0.05, all 
concentrations (0.06,0.08,0.10, and 0.12 g/mL) are significantly different from one 
another (Figure 60). In Figure 61, the different concentrations for all three of the 
cartilage chip groups combined are analyzed according to pore size in the same manner 
as was done for fiber diameter in Figure 60. For the pore size of all three groups, the 
concentrations of 0.06 and 0.08 are not significantly different. The concentrations of 
0.10 and 0.12 are also not significantly different. The two sets of concentrations are 
significantly different from each other in terms of pore size when all three of the cartilage 
chips groups are combined. 
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Figure 58: Tukey's One Way Analysis of the Lampire, Spear, and Fetal Cartilage Chip 
Groups According to Fiber Diameter 
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Figure 59: Tukey's One Way Analysis of the Lampire, Spear, and Fetal Cartilage Chlp 
Groups According to Pore Size 
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Figure 61: Tukey's One Way Analysis of Pore Size for Lampire, Spear, and Fetal 
Cartilage Chips According to Concentration 
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Discussion 
For the first run of the collagen type I1 extraction, there were three major mistakes 
that were made, which led to much smaller end yields than were expected. The first 
mistake was the blender used to grind the cartilage chips in step #2. Only a Hamilton 
Beach 14 speed blender (model #54252B) was used with 400 Watts of power (0.5 
horsepower), but a Waring blender with a minimum of three horsepower was necessary 
for the proper maceration of the cartilage chips. The type I1 collagen cannot be fully 
extracted if the pieces of cartilage are too large. The blender utilized barely made the 
pieces any smaller for this first extraction then when the pieces were cut by hand. The 
second mistake was made in step # 10, which was that the pepsin extracted collagen type 
I1 supernatant was not left out at room temperature overnight after the 5 M NaCl was 
added. Instead, the solution was placed in the refrigerator because of the possibility of 
denaturalization of the material. Leaving this solution out at room temperature actually 
precipitates the collagen. Lastly, when preparing the sample solution for the SDS-Page, 
the material used was the actual dialyzed collagen solution from step #22. When the final 
material (liquid form before freezing and lyophilization) from step #22 was used, there 
was no way to measure the concentration of type I1 collagen in the dilute acetic acid 
because it was so low (difficult to detect). If the lyophilized collagen was used (as was 
done in the third extraction), the dissolved concentration is known and can be made equal 
to that of the standards. 
77 
When comparing the SEM pictures for the fetal cartilage chip group from the 
first extraction, Figures 19,20 and 21 (0.13,O. 14,O. 15 g/inL) are a bit different from the 
rest. There is a combination of smaller and larger fibers. This could be due to the fact 
that these are the higher concentrations and the dissolved material was very thick and was 
sputtering out of the needle. It is also possible that the material may not have been mixed 
properly due to the presence of a high level of viscosity or there may have been a 
contamination issue. 
For the second extraction, the correct blender was utilized for the second step of 
the collagen type TI extraction. A Waring CB 15 three horsepower blender was used to 
blend the chips into a fine milkshake consistency. There was still a problem with getting 
an acceptable yield for the three batches and that was due to the addition of salt to begin 
the precipitation in step # 10 of the collagen type I1 extraction process. The speed of the 
addition of the 5M salt to the solution is critical. It must be added slowly and not create 
any disturbance in the solution (bubbles). During this extraction, the carboy of 5M NaCl 
was placed above the container of the stirring solution and to allow the salt to drip into 
the container below in a stream-like fashion (not a slow drip). The speed of the addition 
was too fast, which can cause an improper precipitation of the collagen type 11. The 
solution was left out at room temperature and a there was an actual cloudiness in the 
solution, which was a visible sign that the collagen type I1 had precipitated. This was not 
seen in the first extraction. For the first extraction the solution was completely clear 
when taken out of the refrigerator after the salt precipitation. This proved that leaving the 
solution at room temperature overnight does play a vital role in the collagen type I1 
precipitation. In the second extraction, a SDS Page was performed, but absolutely 
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nothing showed up on the gel. This was due to the mistake of not actually taking the 
lyophilized collagen and dissolving it in dilute acetic acid to be used in the SDS Page. 
Instead, we used the liquid material from step #22 which will have a very small collagen 
concentration (also unknown concentration). The concentration was even smaller for this 
processing run as compared to the first as is shown by the smaller calculated percent 
yield for the three batches. Once this was realized, it was too late to repeat the SDS Page 
because all of the lyophilized collagen type I1 was used to make an attempt to spin the 
type I1 collagen from the three groups of cartilage chips. Again, for this run, the 
electrospinning results were inconsistent due to the small amounts of material that were 
extracted from the three groups. The ideal concentrations were electrospun (0.06,0.08, 
0.10, and 0.12 g/mL), but only the Lampire bovine cartilage chip group gave a yield of 
lyophilized collagen type I1 material in an amount large enough for the electrospinning 
procedure. 
After two trials, we were able to detect and correct many errors. For the third 
extraction, the correct blender was used, the salt was added at a drip by drip speed when 
precipitating the collagen type 11, and the material was left out overnight at room 
temperature after the salt precipitation. There was enough end product from all three 
cartilage chip groups to perform both electrospinning at all four concentrations and a 
SDS-Page. The end product was greatest for this extraction for all three cartilage chip 
types. This extraction allowed us to create much more comparable results because the 
same four concentrations were electrospun for all three groups and the same 
concentration of type I1 collagen actual lyophilized end product dissolved in dilute acetic 
acid was used to run the SDS-Page. In the first trial, only the fetal bovine chips spun well 
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while the Lampire and Spear chips could only be spun at certain concentrations. In the 
second trial, only the Lampire chips produced material that could be electrosp~~n a d the 
material from the other two groups were wasted during the attempt to spin scaffolds, 
leaving no material for purity testing. This final third extraction yielded enough material 
to both run a SDS page to assure the material was pure collagen type I1 without any type I 
contamination and to electrospin each of the three cartilage chip groups at the desired 
concentrations of 0.06,0.08,0.10, and 0.12 g/mL HFP for the analysis of fiber diameter 
and pore size. 
The main goal of this experiment was the extraction and electrospinning of type I1 
collagen from the cartilage of bovine specimens. This was achieved for bovine 
specimens ranging from fetal to six months old. It was proven that through the 
manipulation of concentration of the dissolved collagen type I1 in HFP, the fiber diameter 
and pore size can be increased or decreased according to the desired size. This allows the 
collagen type 11 scaffold to have the ability to suit any need according to the size of the 
cell that will need to infiltrate into the scaffold. An optimal scaffold can be spun once the 
proper parameters are determined. Electrospinning is a method of creating scaffolds that 
has many variables including voltage, mandrel speed, distance between the mandrel and 
needle, and pump speed. The machine used to create the scaffolds in this experiment has 
room for error when adjusting the mandrel speed. There is no precise way to assure that 
the mandrel is spinning at the exact same RPM for the duration of the time the scaffold is 
constructed and there may be a difference when electrospinning one scaffold as compared 
to another at the same RPM setting. It was proven in the experiment that for all three 
cartilage groups, both fiber diameter and pore size increase as concentration increases. 
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As concentration decreases the opposite occurs. This is a highly important factor in 
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tailoring an ideal matrix. 
Both temperature and humidity may also affect the electrospinning of the 
scaffolds. Sometimes there may also be a charge build-up at the site where the material 
leaves the end of the syringe that is to be deposited onto the mandrel. A system design 
that is more highly enclosed with a highly precise way to measure the consistency at 
which the mandrel rotates may give the ability to have a much more regular fiber 
diameter and pore size. There is still quite a bit of variation in the scaffolds that were 
electrospun for this project. 
The ability to electrospin an entire scaffold and not just onto a SEM pellet is 
highly important. Due to the small yields that were extracted during this experiment, we 
were unable to do so, but the processing technique has now been refined. Once the 
material is electrospun into mats, the material properties can be analyzed according to the 
varying concentration utilized to electrospin the mats. 
The yield results for the three processing runs were inconsistent. This was due to 
the fact that there were many processing errors that were worked out along the way. For 
the first run, the fetal group had the highest percent yield, but for both the second and 
third run, the Spear cartilage chip group had the highest yield. This could be due to the 
possibility that the chips were manually scraped and had no contamination of blood 
vessels or bone marrow. For the second and third processing runs, the fetal chip group 
had the lowest yield and the Lampire chip group was in the middle. 
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Future Work 
There is a great deal of work that needs to be done now that it has been proven 
that type I1 collagen can be extracted and electrospun. Articular cartilage poses a great 
problem to the aging society. The idea that collagen type I1 can be electrospun into any 
desired shape and size and manipulated to have the desirable pore size and fiber diameter 
for the seeding of chondrocytes gives great possibility for a tissue engineered product. 
The testing of the mechanical properties is highly important because it must be durable 
enough to resist high loads, yet porous eiiough to allow for the synovial fluid to flow in 
and out of the tissue to deliver the needed nutrients to the chondrocytes. It is likely that 
the collagen type I1 scaffold will need to be blended with a polymer to increase the 
strength. There are many FDA friendly polymers that are available that have minimal 
rejection from the body, such as PDS. Once the mechanical properties for tensile 
strength, modulus of elasticity, peak load, peak stress, and strain at break are determined 
to be the best match to that of the articular cartilage tissue inside the body, then this 
material will be chosen for the seeding of chondrocytes. Next, the concentration of this 
material must be chosen. The desired pore size and fiber diameter for optimal infiltration 
and regeneration of chondrocytes must be determined and the scaffold can be 
manipulated by varying the concentration to fit within these parameters. The scaffold 
should then be seeded with chondrocytes to see how the cells interact with the material. 
The use of a combination of a natural and synthetic material would be optimal 
because the natural material will help with the possibility of rejection and will also be 
recognizable as "home" for the cells. Cells will be able to identify this familiar material 
as being similar to that of their natural environment. The adchtion of the synthetic 
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material will allow for a better determination of degradation rate inside the body. It 
will also increase the consistency of the material. Synthetic materials are produced in a 
highly regulated fashion, whereas the extraction of natural materials can often times be 
inconsistent from batch to batch. 
The addition of growth factors or the use of stem cells is also an additional 
possibility once the optimal scaffold has been chosen. Once the scaffold has proven to 
allow chondrocytes to infiltrate, proliferate and regenerate, the scaffold will be ready for 
testing in vivo. The idea of a tissue engineered product made predominately of collagen 
type I1 could give many possibilities for the remedy of osteoarthritis or any other injuries 
to the joints of aging individuals. 
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